NICLOCIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Niclocide, and when can generic versions of Niclocide launch?
Niclocide is a drug marketed by Bayer Pharms and is included in one NDA.
The generic ingredient in NICLOCIDE is niclosamide. There are three drug master file entries for this compound. Additional details are available on the niclosamide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NICLOCIDE?
- What are the global sales for NICLOCIDE?
- What is Average Wholesale Price for NICLOCIDE?
Summary for NICLOCIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 104 |
| Patent Applications: | 3,355 |
| DailyMed Link: | NICLOCIDE at DailyMed |
US Patents and Regulatory Information for NICLOCIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Pharms | NICLOCIDE | niclosamide | TABLET, CHEWABLE;ORAL | 018669-001 | May 14, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
